URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Scott McNitt

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Defibrillators, Implantable
61
2004
373
6.780
Why?
Death, Sudden, Cardiac
38
2004
246
4.360
Why?
Long QT Syndrome
33
2005
346
4.120
Why?
Heart Failure
30
2004
337
3.610
Why?
Cardiac Resynchronization Therapy
18
2010
71
3.130
Why?
Ventricular Dysfunction, Left
25
2004
149
2.890
Why?
Myocardial Infarction
29
2005
630
2.820
Why?
Tachycardia, Ventricular
19
2004
146
2.380
Why?
Electrocardiography
38
2005
719
2.260
Why?
Proportional Hazards Models
38
2004
398
1.760
Why?
KCNQ1 Potassium Channel
9
2007
63
1.650
Why?
Ventricular Fibrillation
13
2004
89
1.540
Why?
Heart Arrest
16
2004
131
1.540
Why?
Risk Assessment
36
2004
808
1.540
Why?
Risk Factors
56
2004
2172
1.510
Why?
Male
114
1980
18870
1.490
Why?
Romano-Ward Syndrome
7
2007
30
1.490
Why?
Ether-A-Go-Go Potassium Channels
9
2006
48
1.480
Why?
Female
112
2004
19061
1.450
Why?
Adrenergic beta-Antagonists
18
2005
152
1.350
Why?
Aged
67
2004
6986
1.270
Why?
Mutation
12
2006
1183
1.270
Why?
Middle Aged
68
2004
9461
1.230
Why?
Heart Conduction System
10
2004
144
1.210
Why?
Treatment Outcome
41
2004
2487
1.200
Why?
Electric Countershock
10
2004
88
1.160
Why?
Heart Rate
14
2005
449
1.130
Why?
Humans
119
1978
35000
1.100
Why?
Atrial Fibrillation
7
2006
110
1.080
Why?
Syncope
12
2006
94
0.970
Why?
Kaplan-Meier Estimate
20
2007
190
0.940
Why?
Arrhythmias, Cardiac
9
2004
224
0.910
Why?
Stroke Volume
14
2005
140
0.880
Why?
Genotype
17
2007
455
0.860
Why?
Cardiomyopathies
6
2010
75
0.850
Why?
Follow-Up Studies
29
2004
1757
0.810
Why?
European Continental Ancestry Group
5
2006
225
0.800
Why?
Adult
43
2005
10906
0.800
Why?
Genetic Predisposition to Disease
12
2006
306
0.770
Why?
Myocardial Ischemia
8
2005
112
0.750
Why?
Survival Analysis
21
2004
575
0.720
Why?
Cause of Death
9
2004
155
0.710
Why?
African Continental Ancestry Group
3
2006
116
0.680
Why?
Young Adult
15
2008
1013
0.670
Why?
Arrhythmogenic Right Ventricular Dysplasia
1
2009
18
0.640
Why?
Survival Rate
18
2005
584
0.640
Why?
Hemostasis, Surgical
1
2008
12
0.640
Why?
Punctures
1
2008
25
0.630
Why?
Coagulants
1
2008
13
0.630
Why?
Adolescent
23
2005
4513
0.630
Why?
Ventricular Function, Left
4
2011
88
0.620
Why?
Mutation, Missense
4
2007
81
0.610
Why?
Femoral Artery
1
2008
80
0.610
Why?
Angioplasty, Balloon, Coronary
1
2008
60
0.610
Why?
Electrocardiography, Ambulatory
6
2007
91
0.590
Why?
Time Factors
20
2004
3047
0.590
Why?
Prospective Studies
15
2005
1606
0.580
Why?
Echocardiography
11
2007
202
0.580
Why?
Registries
13
2006
203
0.580
Why?
Chi-Square Distribution
12
2006
320
0.580
Why?
Prognosis
18
2004
1030
0.570
Why?
Hemorrhage
1
2008
173
0.560
Why?
Retrospective Studies
18
2004
2167
0.550
Why?
Child
17
2006
3897
0.530
Why?
Multivariate Analysis
13
2008
487
0.510
Why?
Heart Diseases
1
2006
132
0.510
Why?
Phenotype
9
2006
727
0.490
Why?
Incidence
11
2006
644
0.470
Why?
Ventricular Remodeling
4
2010
34
0.460
Why?
Child, Preschool
14
2006
2452
0.450
Why?
Recurrence
9
2006
656
0.450
Why?
Infant
13
2006
2102
0.450
Why?
Myocardial Contraction
3
2011
107
0.420
Why?
Heart
3
2010
228
0.380
Why?
Sex Factors
10
2005
561
0.370
Why?
Aza Compounds
4
2006
21
0.370
Why?
Smoking
3
2006
387
0.360
Why?
Quinolines
4
2006
42
0.360
Why?
Sodium Channels
3
2008
117
0.350
Why?
Jervell-Lange Nielsen Syndrome
2
2006
9
0.330
Why?
Diabetes Mellitus
2
2009
162
0.330
Why?
United States
8
2005
2511
0.320
Why?
Myocardial Revascularization
2
2006
21
0.320
Why?
Infant, Newborn
8
2007
1772
0.320
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2006
43
0.320
Why?
Catheter Ablation
2
2009
72
0.310
Why?
Muscle Proteins
2
2008
131
0.300
Why?
Sequence Deletion
2
2007
123
0.300
Why?
Polymorphism, Genetic
3
2006
191
0.300
Why?
Codon, Nonsense
2
2007
54
0.300
Why?
Severity of Illness Index
9
2005
878
0.300
Why?
Membrane Potentials
2
2007
338
0.290
Why?
Cardiovascular Diseases
4
2004
250
0.290
Why?
Anti-Arrhythmia Agents
2
2006
80
0.280
Why?
Models, Molecular
2
2007
350
0.270
Why?
DNA
2
2011
831
0.270
Why?
Logistic Models
6
2004
581
0.270
Why?
Anti-Infective Agents
4
2006
74
0.260
Why?
Predictive Value of Tests
7
2005
579
0.250
Why?
Cohort Studies
9
2004
912
0.250
Why?
Age Distribution
6
2007
201
0.240
Why?
Statistics, Nonparametric
6
2004
251
0.240
Why?
Ventricular Premature Complexes
2
2008
18
0.230
Why?
Ion Channels
2
2010
149
0.220
Why?
Aged, 80 and over
9
2006
2423
0.220
Why?
Multicenter Studies as Topic
4
2004
126
0.220
Why?
Smoking Cessation
2
2006
77
0.220
Why?
Ventricular Dysfunction, Right
2
2009
17
0.210
Why?
Canada
2
2009
75
0.210
Why?
Tobacco Use Cessation Products
1
2012
3
0.210
Why?
Age Factors
6
2006
1060
0.210
Why?
Acute Coronary Syndrome
1
2012
7
0.200
Why?
Sex Distribution
5
2007
142
0.200
Why?
Diabetic Angiopathies
1
2012
31
0.190
Why?
Odds Ratio
5
2004
301
0.190
Why?
Torsades de Pointes
2
2008
32
0.190
Why?
Risk
5
2004
343
0.190
Why?
Coronary Care Units
1
2011
16
0.190
Why?
Heart-Assist Devices
1
2011
33
0.190
Why?
Cardiomyopathy, Dilated
1
2011
33
0.190
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2006
48
0.190
Why?
Randomized Controlled Trials as Topic
4
2004
400
0.190
Why?
Cardiac Pacing, Artificial
2
2010
151
0.190
Why?
Menopause
1
2011
40
0.190
Why?
Cardiac Resynchronization Therapy Devices
1
2011
12
0.190
Why?
Age of Onset
2
2007
120
0.190
Why?
Heterozygote
2
2007
120
0.190
Why?
Patient Admission
1
2011
77
0.180
Why?
Heart Block
1
2011
55
0.180
Why?
Electrodes, Implanted
1
2011
53
0.180
Why?
Ambulatory Care
1
2011
140
0.180
Why?
Hypothermia, Induced
1
2010
29
0.180
Why?
Autonomic Nervous System
1
2010
69
0.180
Why?
Diagnosis, Computer-Assisted
2
2007
64
0.180
Why?
Electrophysiologic Techniques, Cardiac
2
2005
23
0.180
Why?
Polymorphism, Single Nucleotide
2
2007
87
0.170
Why?
Death
1
2010
22
0.170
Why?
Cardiomegaly
1
2010
44
0.170
Why?
Delayed Rectifier Potassium Channels
2
2006
10
0.170
Why?
Heart Atria
1
2010
62
0.170
Why?
Protein Structure, Secondary
1
2009
84
0.170
Why?
Ventricular Function, Right
2
2005
26
0.170
Why?
Ion Channel Gating
1
2011
126
0.170
Why?
Coronary Artery Bypass
1
2010
105
0.160
Why?
Glomerular Filtration Rate
2
2006
82
0.160
Why?
Cardiology
1
2010
51
0.160
Why?
Early Ambulation
1
2008
5
0.160
Why?
Angiography
1
2009
89
0.160
Why?
Models, Biological
2
2011
982
0.160
Why?
Body Mass Index
1
2010
207
0.160
Why?
Ventricular Dysfunction
1
2008
7
0.160
Why?
Sotalol
1
2008
16
0.160
Why?
Conserved Sequence
1
2009
102
0.160
Why?
Acetanilides
1
2008
9
0.160
Why?
Administration, Topical
1
2008
88
0.160
Why?
Pressure
1
2008
126
0.160
Why?
Asian Continental Ancestry Group
1
2008
29
0.150
Why?
Adrenergic beta-Agonists
1
2008
52
0.150
Why?
Tachycardia, Supraventricular
1
2008
19
0.150
Why?
New York
5
2005
1191
0.150
Why?
Siblings
1
2008
35
0.150
Why?
Physicians
1
2010
143
0.150
Why?
Atrial Flutter
1
2008
24
0.150
Why?
Medical History Taking
1
2008
59
0.150
Why?
Piperazines
1
2008
71
0.150
Why?
Genetic Variation
1
2008
148
0.150
Why?
Cholesterol Ester Transfer Proteins
1
2007
14
0.150
Why?
African Americans
1
2010
209
0.150
Why?
Frameshift Mutation
1
2007
21
0.140
Why?
Japan
1
2007
28
0.140
Why?
RNA Splice Sites
1
2007
15
0.140
Why?
Coronary Artery Disease
1
2008
85
0.140
Why?
Sodium
1
2008
296
0.140
Why?
Netherlands
1
2007
28
0.140
Why?
Aryldialkylphosphatase
1
2007
5
0.140
Why?
Pregnancy, High-Risk
1
2007
10
0.140
Why?
Physician's Practice Patterns
1
2010
223
0.140
Why?
Hospitalization
5
2004
354
0.140
Why?
Mutagenesis, Insertional
1
2007
52
0.140
Why?
Ion Transport
1
2007
69
0.140
Why?
Probability
4
2004
289
0.140
Why?
Kidney
1
2010
581
0.140
Why?
Primary Prevention
1
2007
52
0.140
Why?
Pregnancy Complications, Cardiovascular
1
2007
35
0.140
Why?
Attitude of Health Personnel
1
2010
267
0.140
Why?
Angiotensinogen
1
2006
7
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
247
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
64
0.140
Why?
Bundle-Branch Block
3
2011
44
0.140
Why?
Protein Transport
1
2007
160
0.130
Why?
Mental Health
1
2007
83
0.130
Why?
Confidence Intervals
3
2007
155
0.130
Why?
Potassium
1
2007
303
0.130
Why?
Flecainide
1
2005
12
0.130
Why?
Pregnancy Outcome
1
2007
136
0.130
Why?
Kidney Failure, Chronic
1
2007
117
0.130
Why?
Protein Structure, Tertiary
1
2007
347
0.130
Why?
Tachycardia
1
2005
64
0.130
Why?
Diabetes Complications
1
2005
60
0.120
Why?
Asthma
1
2008
282
0.120
Why?
Blood Pressure
1
2007
446
0.120
Why?
Obesity
1
2007
301
0.110
Why?
Hypertension
1
2006
285
0.110
Why?
Spain
2
2012
19
0.100
Why?
Minnesota
2
2010
22
0.100
Why?
Echocardiography, Doppler
2
2011
48
0.090
Why?
Europe
2
2011
74
0.090
Why?
Sensitivity and Specificity
3
2006
866
0.090
Why?
World Health
2
2011
59
0.090
Why?
Systole
2
2009
38
0.090
Why?
Exercise
2
2010
155
0.080
Why?
Hospital Mortality
2
2008
131
0.080
Why?
Equipment Failure
2
2008
70
0.080
Why?
Clinical Trials as Topic
3
2004
664
0.080
Why?
Blood Urea Nitrogen
2
2005
42
0.080
Why?
Electrophysiology
2
2005
243
0.070
Why?
Analysis of Variance
2
2007
705
0.070
Why?
Regression Analysis
2
2007
489
0.070
Why?
Reproducibility of Results
2
2007
859
0.070
Why?
Pacemaker, Artificial
2
2008
158
0.070
Why?
Life Tables
2
2004
35
0.060
Why?
Disease Progression
2
2004
496
0.060
Why?
Algorithms
2
2007
518
0.050
Why?
Heart Function Tests
1
2012
29
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
59
0.050
Why?
Disease-Free Survival
1
2012
191
0.050
Why?
Precipitating Factors
1
2011
5
0.050
Why?
Prosthesis Design
1
2011
60
0.050
Why?
Electric Conductivity
1
2011
85
0.050
Why?
Israel
1
2011
30
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
Cardiotoxins
1
2011
3
0.050
Why?
Sleep
1
2011
56
0.050
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.050
Why?
Amino Acid Substitution
1
2011
118
0.050
Why?
Drug Evaluation, Preclinical
1
2011
72
0.050
Why?
Blood Volume
1
2010
51
0.050
Why?
Arousal
1
2010
54
0.040
Why?
Monitoring, Physiologic
1
2010
94
0.040
Why?
Blood Circulation
1
2010
38
0.040
Why?
DNA Mutational Analysis
1
2011
185
0.040
Why?
Creatinine
1
2010
128
0.040
Why?
Exercise Test
1
2010
88
0.040
Why?
Guidelines as Topic
1
2011
87
0.040
Why?
Case-Control Studies
1
2012
587
0.040
Why?
Oocytes
1
2011
134
0.040
Why?
Echocardiography, Transesophageal
1
2010
52
0.040
Why?
Family
1
2011
198
0.040
Why?
Heart Ventricles
1
2011
192
0.040
Why?
Xenopus laevis
1
2011
168
0.040
Why?
Organ Size
1
2010
189
0.040
Why?
Obesity, Morbid
1
2010
49
0.040
Why?
Guideline Adherence
1
2010
72
0.040
Why?
Drug Therapy, Combination
2
1978
375
0.040
Why?
Kidney Diseases
1
2011
167
0.040
Why?
Computer Simulation
1
2011
295
0.040
Why?
Health Care Surveys
1
2010
139
0.040
Why?
Continental Population Groups
1
2010
116
0.040
Why?
Physicians, Family
1
2010
98
0.040
Why?
Computational Biology
1
2009
66
0.040
Why?
Patient Selection
1
2010
197
0.040
Why?
Referral and Consultation
1
2010
188
0.040
Why?
Angina Pectoris
1
2008
48
0.040
Why?
Discriminant Analysis
1
2007
21
0.040
Why?
Point Mutation
1
2008
169
0.040
Why?
Practice Guidelines as Topic
1
2010
288
0.040
Why?
Combined Modality Therapy
1
2008
459
0.040
Why?
Lipids
1
2007
164
0.040
Why?
Postpartum Period
1
2007
37
0.040
Why?
Glutamine
1
2007
62
0.030
Why?
Aspartic Acid
1
2007
45
0.030
Why?
Parity
1
2007
47
0.030
Why?
Arginine
1
2007
107
0.030
Why?
Threonine
1
2006
25
0.030
Why?
Methionine
1
2006
52
0.030
Why?
Gene Frequency
1
2006
83
0.030
Why?
Homozygote
1
2006
91
0.030
Why?
Glutamic Acid
1
2007
95
0.030
Why?
Enzyme Inhibitors
1
2008
396
0.030
Why?
ROC Curve
1
2006
119
0.030
Why?
Models, Cardiovascular
1
2006
67
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Biological Markers
1
2008
532
0.030
Why?
Gestational Age
1
2007
334
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Metoprolol
1
2005
10
0.030
Why?
Atenolol
1
2005
12
0.030
Why?
Placebo Effect
1
2005
36
0.030
Why?
Tomography, X-Ray Computed
1
2010
729
0.030
Why?
Carbazoles
1
2005
27
0.030
Why?
Amino Acid Sequence
1
2009
1198
0.030
Why?
Mortality
1
2006
87
0.030
Why?
Placebos
1
2006
177
0.030
Why?
Equipment Failure Analysis
1
2005
68
0.030
Why?
Equipment Design
1
2006
244
0.030
Why?
Outcome Assessment (Health Care)
1
2008
275
0.030
Why?
Survivors
1
2006
112
0.030
Why?
Action Potentials
1
2006
248
0.030
Why?
Prevalence
1
2007
530
0.030
Why?
Research Design
1
2006
326
0.030
Why?
Coronary Disease
1
2006
247
0.030
Why?
Molecular Sequence Data
1
2009
1993
0.030
Why?
Comorbidity
1
2005
365
0.030
Why?
Quality of Life
1
2007
486
0.030
Why?
Double-Blind Method
1
2005
985
0.030
Why?
Pregnancy
1
2007
1919
0.020
Why?
Doxorubicin
2
1978
102
0.020
Why?
Daunorubicin
1
1980
25
0.020
Why?
Neoplasms, Experimental
1
1980
146
0.020
Why?
Leukemia, Lymphoid
1
1978
63
0.020
Why?
Cyclophosphamide
1
1978
169
0.020
Why?
Animals
3
1978
15647
0.020
Why?
Leukemia, Experimental
2
1978
20
0.010
Why?
Melanoma
1
1980
133
0.000
Why?
Cell Survival
1
1980
537
0.000
Why?
Mice
2
1978
5900
0.000
Why?
DNA, Neoplasm
1
1978
127
0.000
Why?
Cell Count
1
1978
279
0.000
Why?
Kinetics
1
1980
1377
0.000
Why?
Drug Administration Schedule
1
1978
362
0.000
Why?
Bone Marrow
1
1978
282
0.000
Why?
Cell Line
1
1980
1554
0.000
Why?

Visualizations


McNitt's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department